High frequency of HPV16 European variant E350G among Mexican women from Sinaloa

Indian J Med Res. 2018 Sep;148(3):323-328. doi: 10.4103/ijmr.IJMR_61_17.

Abstract

Background & objectives: Human papillomavirus (HPV) infections play a crucial role in the aetiology of cervical cancer (CC), and HPV16 is the primary viral genotype associated with CC. A number of variants of the HPV16 E6 gene are involved in the progression of CC, differing in their prevalence and biological and biochemical properties. This study was designed to determine the frequency of HPV types 16/18 and to identify the presence of HPV16 E6-variants in asymptomatic Mexican women.

Methods: A total of 189 cervical Pap smears were collected from women attending public health services in three different cities in Sinaloa, Mexico. Viral DNA was identified by amplification of E6 viral gene fragments using polymerase chain reaction (PCR). Identification of variants was done by sequencing a DNA fragment (321bp) of the HPV16 E6 gene.

Results: More than half of the women tested were HPV-positive (52.38%), with HPV16 being the most frequent genotype (21.16%), followed by HPV18 (8.99%). Sequence analysis of the E6-HPV16 PCR products showed that in all cases, the viruses corresponded to European variants. It was further observed that the E350G intra-variant was the most common (>76%).

Interpretation & conclusions: This study showed a predominance of European lineage variants of HPV16 among asymptomatic women from Sinaloa, Mexico, predominantly with of the E350G variant. This variant has been shown to be associated with an increased risk of early development of CC. The use of molecular identification of carcinogenic HPV and Pap test screening may be a good strategy for monitoring women to prevent CC.

Keywords: Cervical cancer; European variant; human papillomavirus; molecular diagnostics.

MeSH terms

  • Adult
  • Disease Progression
  • Female
  • Genetic Variation
  • Humans
  • Mexico / epidemiology
  • Oncogene Proteins, Viral / genetics*
  • Papillomaviridae* / classification
  • Papillomaviridae* / genetics
  • Papillomaviridae* / pathogenicity
  • Papillomavirus Infections* / diagnosis
  • Papillomavirus Infections* / ethnology
  • Papillomavirus Infections* / virology
  • Repressor Proteins / genetics*
  • Sequence Analysis, DNA / methods
  • Uterine Cervical Neoplasms* / ethnology
  • Uterine Cervical Neoplasms* / virology

Substances

  • E6 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • Repressor Proteins